Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
APCOTEXIND.NS Stock Summary
Top 10 Correlated ETFs
APCOTEXIND.NS
In the News
APCOTEXIND.NS Financial details
Company Rating
Buy
Market Cap
23.78B
Income
617.76M
Revenue
10.59B
Book val./share
-
Cash/share
-
Dividend
5.5
Dividend %
1.09%
Employees
553
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
36.73
Forward P/E
-
PEG
-9.8
P/S
2.51
P/B
5.26
P/C
-
P/FCF
-
Quick Ratio
1
Current Ratio
1.65
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
11.92
EPS next Y
-
EPS next Q
-
EPS this Y
9.23%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
18.29%
Revenue last 5Y
11.41%
Revenue Q/Q
-7.97%
EPS Q/Q
-27.12%
-
-
-
-
SMA20
7.42%
SMA50
-3.14%
SMA100
-12.97%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
29%
ROC
0.16%
Gross Margin
31%
Oper. Margin
10%
Profit Margin
7%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
400.0-588.0
52W High
-20.68%
52W Low
+16.6%
RSI
59
Rel Volume
1.97
Avg Volume
49.52K
Volume
97.75K
Perf Week
1.82%
Perf Month
-0.06%
Perf Quarter
-4.6%
Perf Half Y
-11.2%
-
-
-
-
Beta
0.46
-
-
Volatility
5.95%, 20.42%
Prev Close
0%
Price
466.4
Change
3.21%
APCOTEXIND.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 120.18 | 94.81 | 103.75 | 183.46 | 206.24 | |
Net income per share | 8.99 | 3.21 | 8.52 | 19.06 | 20.82 | |
Operating cash flow per share | 7.49 | 7.01 | 14.51 | 9.17 | 23.41 | |
Free cash flow per share | 3.2 | -2.68 | 9.93 | -3.94 | -12.66 | |
Cash per share | 6.14 | 6.32 | 4.8 | 5.12 | 7.22 | |
Book value per share | 53.57 | 48.47 | 58.91 | 76.41 | 91.81 | |
Tangible book value per share | 53.3 | 48.28 | 58.78 | 76.3 | 91.73 | |
Share holders equity per share | 53.57 | 48.47 | 58.91 | 76.41 | 91.81 | |
Interest debt per share | 1.07 | 9.71 | 3.5 | 10.25 | 30.15 | |
Market cap | 10.81B | 4.01B | 9.31B | 18.61B | 25.28B | |
Enterprise value | 10.79B | 4.39B | 9.35B | 19.09B | 26.64B | |
P/E ratio | 23.2 | 24.12 | 21.09 | 18.83 | 23.42 | |
Price to sales ratio | 1.74 | 0.82 | 1.73 | 1.96 | 2.36 | |
POCF ratio | 27.84 | 11.04 | 12.38 | 39.14 | 20.83 | |
PFCF ratio | 65.22 | -28.85 | 18.09 | -91.17 | -38.51 | |
P/B Ratio | 3.89 | 1.6 | 3.05 | 4.7 | 5.31 | |
PTB ratio | 3.89 | 1.6 | 3.05 | 4.7 | 5.31 | |
EV to sales | 1.73 | 0.89 | 1.74 | 2.01 | 2.49 | |
Enterprise value over EBITDA | 14.74 | 11.72 | 12.75 | 13.13 | 16.23 | |
EV to operating cash flow | 27.8 | 12.08 | 12.43 | 40.15 | 21.95 | |
EV to free cash flow | 65.12 | -31.55 | 18.17 | -93.54 | -40.59 | |
Earnings yield | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | |
Free cash flow yield | 0.02 | -0.03 | 0.06 | -0.01 | -0.03 | |
Debt to equity | 0.01 | 0.2 | 0.05 | 0.13 | 0.32 | |
Debt to assets | 0.01 | 0.12 | 0.03 | 0.08 | 0.19 | |
Net debt to EBITDA | -0.02 | 1 | 0.05 | 0.33 | 0.83 | |
Current ratio | 2.37 | 1.85 | 1.75 | 1.84 | 1.79 | |
Interest coverage | 36.28 | 19.98 | 15.8 | 44.01 | 31.71 | |
Income quality | 0.63 | 1.48 | 1.33 | 0.36 | 0.83 | |
Dividend Yield | 0.01 | 0.08 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.26 | 1.84 | 0.18 | 0.21 | 0.24 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.57 | -1.38 | -0.32 | -1.43 | -1.54 | |
Capex to revenue | -0.04 | -0.1 | -0.04 | -0.07 | -0.17 | |
Capex to depreciation | -1.89 | -3.75 | -1.64 | -4.82 | -12.28 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 104.09 | 59.14 | 106.25 | 181.01 | 207.39 | |
ROIC | 0.15 | 0.05 | 0.14 | 0.22 | 0.17 | |
Return on tangible assets | 0.12 | 0.04 | 0.1 | 0.16 | 0.13 | |
Graham Net | 8.64 | 0.31 | -1.15 | -2.27 | -24.87 | |
Working capital | 1.24B | 945.8M | 912.37M | 1.39B | 1.43B | |
Tangible asset value | 2.76B | 2.5B | 3.05B | 3.96B | 4.76B | |
Net current asset value | 1.15B | 596.37M | 671.38M | 947.62M | -49.14M | |
Invested capital | 0.01 | 0.2 | 0.05 | 0.13 | 0.32 | |
Average receivables | 1.12B | 1.15B | 1.15B | 1.43B | 1.57B | |
Average payables | 503.25M | 492.5M | 524.44M | 794.93M | 1.01B | |
Average inventory | 487.36M | 539.2M | 577.51M | 714.73M | 961.04M | |
Days sales outstanding | 68.83 | 83.75 | 79.25 | 64.9 | 49.4 | |
Days payables outstanding | 42.98 | 47.85 | 62.8 | 58.08 | 52.23 | |
Days of inventory on hand | 39.39 | 62.16 | 59.47 | 50.58 | 53.76 | |
Receivables turnover | 5.3 | 4.36 | 4.61 | 5.62 | 7.39 | |
Payables turnover | 8.49 | 7.63 | 5.81 | 6.28 | 6.99 | |
Inventory turnover | 9.27 | 5.87 | 6.14 | 7.22 | 6.79 | |
ROE | 0.17 | 0.07 | 0.14 | 0.25 | 0.23 | |
Capex per share | -4.29 | -9.69 | -4.58 | -13.11 | -36.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 45.16 | 47.34 | 53.57 | 53.86 | 49.57 | |
Net income per share | 3.93 | 4.48 | 2.34 | 2.95 | 2.15 | |
Operating cash flow per share | 1.44 | 1.58 | 2.85 | 3.01 | 3.18 | |
Free cash flow per share | 1.44 | 1.58 | 2.85 | 3.01 | 3.18 | |
Cash per share | 0 | 7.22 | 0 | 8.29 | 0 | |
Book value per share | 0 | 91.81 | 0 | 95.65 | 0 | |
Tangible book value per share | 0 | 91.73 | 0 | 95.56 | 0 | |
Share holders equity per share | 0 | 91.81 | 0 | 95.65 | 0 | |
Interest debt per share | 0.22 | 29.29 | 0.7 | 37.45 | 0.73 | |
Market cap | 24.16B | 25.28B | 27.55B | 26.42B | 26.17B | |
Enterprise value | 24.16B | 26.64B | 27.55B | 28.24B | 26.17B | |
P/E ratio | 29.65 | 27.23 | 56.83 | 43.13 | 58.76 | |
Price to sales ratio | 10.32 | 10.3 | 9.92 | 9.46 | 10.18 | |
POCF ratio | 322.88 | 309.05 | 186.48 | 169.42 | 158.94 | |
PFCF ratio | 322.88 | 309.05 | 186.48 | 169.42 | 158.94 | |
P/B Ratio | 0 | 5.31 | 0 | 5.33 | 0 | |
PTB ratio | 0 | 5.31 | 0 | 5.33 | 0 | |
EV to sales | 10.32 | 10.85 | 9.92 | 10.11 | 10.18 | |
Enterprise value over EBITDA | 74.33 | 76.4 | 100.23 | 84.7 | 95.34 | |
EV to operating cash flow | 322.88 | 325.74 | 186.48 | 181.13 | 158.94 | |
EV to free cash flow | 322.88 | 325.74 | 186.48 | 181.13 | 158.94 | |
Earnings yield | 0.01 | 0.01 | 0 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0 | 0.32 | 0 | 0.38 | 0 | |
Debt to assets | 0 | 0.19 | 0 | 0.22 | 0 | |
Net debt to EBITDA | 0 | 3.91 | 0 | 5.47 | 0 | |
Current ratio | 0 | 1.79 | 0 | 1.65 | 0 | |
Interest coverage | 25.37 | 604.79 | 4.98 | 5.93 | 5.05 | |
Income quality | 0.37 | 0.35 | 1.22 | 1.02 | 1.48 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.03 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 96.17 | 0 | 79.73 | 0 | |
ROIC | 0 | 0.04 | 0 | 0.03 | 0 | |
Return on tangible assets | 0 | 0.03 | 0 | 0.02 | 0 | |
Graham Net | 0 | -24.87 | 0 | -24.91 | 0 | |
Working capital | 304.74M | 1.43B | 300.68M | 1.43B | 0 | |
Tangible asset value | 0 | 4.76B | 0 | 4.95B | 0 | |
Net current asset value | 304.74M | -49.14M | 300.68M | 18.65M | 0 | |
Invested capital | 0 | 0.32 | 0 | 0.38 | 0 | |
Average receivables | 881.84M | 723.55M | 723.55M | 875.32M | 875.32M | |
Average payables | 494.39M | 510.58M | 510.58M | 508.86M | 508.86M | |
Average inventory | 473.77M | 525.45M | 525.45M | 565.04M | 565.04M | |
Days sales outstanding | 0 | 53.06 | 0 | 56.42 | 0 | |
Days payables outstanding | 0 | 52.88 | 0 | 48.68 | 0 | |
Days of inventory on hand | 0 | 54.42 | 0 | 54.06 | 0 | |
Receivables turnover | 0 | 1.7 | 0 | 1.6 | 0 | |
Payables turnover | 0 | 1.7 | 0 | 1.85 | 0 | |
Inventory turnover | 0 | 1.65 | 0 | 1.66 | 0 | |
ROE | 0 | 0.05 | 0 | 0.03 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
APCOTEXIND.NS Frequently Asked Questions
What is Apcotex Industries Limited stock symbol ?
Apcotex Industries Limited is a IN stock and trading under the symbol APCOTEXIND.NS
What is Apcotex Industries Limited stock quote today ?
Apcotex Industries Limited stock price is $466.4 today.
Is Apcotex Industries Limited stock public?
Yes, Apcotex Industries Limited is a publicly traded company.